{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T17:06:22Z","timestamp":1789059982596,"version":"build-2803163510"},"reference-count":44,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,9]],"date-time":"2026-08-09T00:00:00Z","timestamp":1786233600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100008530","name":"European Regional Development Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008530","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013209","name":"Hellenic Foundation for Research and Innovation","doi-asserted-by":"publisher","award":["6123"],"award-info":[{"award-number":["6123"]}],"id":[{"id":"10.13039\/501100013209","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003448","name":"General Secretariat for Research and Innovation","doi-asserted-by":"publisher","award":["T2EDK-02196"],"award-info":[{"award-number":["T2EDK-02196"]}],"id":[{"id":"10.13039\/501100003448","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011929","name":"Programa Operacional Tem\u00e1tico Factores de Competitividade","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100011929","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejcancer.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Cancer"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.ejca.2026.116987","type":"journal-article","created":{"date-parts":[[2026,8,9]],"date-time":"2026-08-09T14:04:20Z","timestamp":1786284260000},"page":"116987","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Liquid biopsy miRNA risk score in bladder cancer: Translational insights from patient-derived xenografts to prognostic stratification"],"prefix":"10.1016","volume":"246","author":[{"given":"Maria-Alexandra","family":"Papadimitriou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0187-6907","authenticated-orcid":false,"given":"Katerina-Marina","family":"Pilala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2773-4883","authenticated-orcid":false,"given":"Konstantina","family":"Panoutsopoulou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Konstantinos","family":"Soureas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1998-3660","authenticated-orcid":false,"given":"Georgios-Christos","family":"Giagkos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2759-0237","authenticated-orcid":false,"given":"Panagiotis","family":"Levis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zoi","family":"Kanaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-7323-3589","authenticated-orcid":false,"given":"Gedeon","family":"Loules","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4716-2333","authenticated-orcid":false,"given":"Maria","family":"Zamanakou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Konstantinos","family":"Stravodimos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Apostolos","family":"Klinakis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2135-9886","authenticated-orcid":false,"given":"Margaritis","family":"Avgeris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Scorilas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejca.2026.116987_bib1","first-page":"229","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.ejca.2026.116987_bib2","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1038\/s41572-023-00468-9","article-title":"Bladder cancer","volume":"9","author":"Dyrskjot","year":"2023","journal-title":"Nat Rev Dis Prim"},{"key":"10.1016\/j.ejca.2026.116987_bib3","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/j.eururo.2024.07.027","article-title":"European Association of Urology guidelines on non-muscle-invasive bladder cancer (TaT1 and carcinoma in situ)\u2013a summary of the 2024 guidelines update","volume":"86","author":"Gontero","year":"2024","journal-title":"Eur Urol"},{"key":"10.1016\/j.ejca.2026.116987_bib4","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.eururo.2023.08.016","article-title":"European Association of Urology guidelines on muscle-invasive and metastatic bladder cancer: summary of the 2023 guidelines","volume":"85","author":"Alfred Witjes","year":"2024","journal-title":"Eur Urol"},{"key":"10.1016\/j.ejca.2026.116987_bib5","doi-asserted-by":"crossref","first-page":"1712","DOI":"10.1016\/S0140-6736(22)01188-6","article-title":"Current best practice for bladder cancer: a narrative review of diagnostics and treatments","volume":"400","author":"Comperat","year":"2022","journal-title":"Lancet"},{"key":"10.1016\/j.ejca.2026.116987_bib6","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1111\/bju.16521","article-title":"Varying the intensity of cystoscopic surveillance for high-risk non-muscle-invasive bladder cancer","volume":"135","author":"Su","year":"2025","journal-title":"BJU Int"},{"key":"10.1016\/j.ejca.2026.116987_bib7","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/j.euo.2019.01.015","article-title":"The cost to medicare of bladder cancer care","volume":"3","author":"Sloan","year":"2020","journal-title":"Eur Urol Oncol"},{"key":"10.1016\/j.ejca.2026.116987_bib8","series-title":"Biology of bladder cancer: from molecular insights to clinical strategies","first-page":"393","article-title":"Blood-based biomarkers for bladder cancer diagnosis and prognosis","author":"Birkenkamp-Demtr\u00f6der","year":"2024"},{"key":"10.1016\/j.ejca.2026.116987_bib9","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1038\/s41392-024-02021-w","article-title":"Liquid biopsy in cancer current: status, challenges and future prospects","volume":"9","author":"Ma","year":"2024","journal-title":"Signal Transduct Target Ther"},{"key":"10.1016\/j.ejca.2026.116987_bib10","article-title":"CDKN2A copy number alteration in bladder cancer: Integrative analysis in patient-derived xenografts and cancer patients","volume":"32","author":"Papadimitriou","year":"2024","journal-title":"Mol Ther Oncol"},{"key":"10.1016\/j.ejca.2026.116987_bib11","doi-asserted-by":"crossref","DOI":"10.3390\/ijms241814374","article-title":"Molecular markers for bladder cancer screening: an insight into bladder cancer and FDA-approved biomarkers","volume":"24","author":"Flores Monar","year":"2023","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.ejca.2026.116987_bib12","doi-asserted-by":"crossref","DOI":"10.3390\/diagnostics10010039","article-title":"Biomarkers for bladder cancer diagnosis and surveillance: a comprehensive review","volume":"10","author":"Batista","year":"2020","journal-title":"Diagnostics"},{"key":"10.1016\/j.ejca.2026.116987_bib13","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.tig.2021.10.002","article-title":"Classical and noncanonical functions of miRNAs in cancers","volume":"38","author":"Dragomir","year":"2022","journal-title":"Trends Genet"},{"key":"10.1016\/j.ejca.2026.116987_bib14","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1016\/j.molmed.2023.07.003","article-title":"Cancer quiescence: non-coding RNAs in the spotlight","volume":"29","author":"Soureas","year":"2023","journal-title":"Trends Mol Med"},{"key":"10.1016\/j.ejca.2026.116987_bib15","doi-asserted-by":"crossref","DOI":"10.1002\/wrna.1735","article-title":"Epi-miRNAs: modern mediators of methylation status in human cancers","volume":"14","author":"Papadimitriou","year":"2023","journal-title":"Wiley Interdiscip Rev RNA"},{"key":"10.1016\/j.ejca.2026.116987_bib16","doi-asserted-by":"crossref","first-page":"2135","DOI":"10.1038\/s41388-024-03076-3","article-title":"MicroRNAs: circulating biomarkers for the early detection of imperceptible cancers via biosensor and machine-learning advances","volume":"43","author":"Metcalf","year":"2024","journal-title":"Oncogene"},{"key":"10.1016\/j.ejca.2026.116987_bib17","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/j.eururo.2025.07.016","article-title":"The role of liquid biopsy in the management of patients with genitourinary malignancies","volume":"88","author":"Maughan","year":"2025","journal-title":"Eur Urol"},{"key":"10.1016\/j.ejca.2026.116987_bib18","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1080\/14737159.2019.1673732","article-title":"Circulating exosomal miRNAs: clinical significance in human cancers","volume":"19","author":"Avgeris","year":"2019","journal-title":"Expert Rev Mol Diagn"},{"key":"10.1016\/j.ejca.2026.116987_bib19","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1186\/1472-6947-8-53","article-title":"Extensions to decision curve analysis, a novel method for evaluating diagnostic tests, prediction models and molecular markers","volume":"8","author":"Vickers","year":"2008","journal-title":"BMC Med Inform Decis Mak"},{"key":"10.1016\/j.ejca.2026.116987_bib20","doi-asserted-by":"crossref","DOI":"10.1016\/j.jlb.2025.100296","article-title":"Circulating miRNAs in genitourinary cancer: pioneering advances in early detection and diagnosis","volume":"8","author":"Cicatiello","year":"2025","journal-title":"J Liq Biopsy"},{"key":"10.1016\/j.ejca.2026.116987_bib21","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1111\/cas.13856","article-title":"Circulating miRNA panels for specific and early detection in bladder cancer","volume":"110","author":"Usuba","year":"2019","journal-title":"Cancer Sci"},{"key":"10.1016\/j.ejca.2026.116987_bib22","doi-asserted-by":"crossref","first-page":"36733","DOI":"10.18632\/oncotarget.9166","article-title":"Serum microRNA expression signatures as novel noninvasive biomarkers for prediction and prognosis of muscle-invasive bladder cancer","volume":"7","author":"Jiang","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.ejca.2026.116987_bib23","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1002\/ijc.29041","article-title":"Serum microRNA expression signatures identified from genome-wide microRNA profiling serve as novel noninvasive biomarkers for diagnosis and recurrence of bladder cancer","volume":"136","author":"Jiang","year":"2015","journal-title":"Int J Cancer"},{"key":"10.1016\/j.ejca.2026.116987_bib24","doi-asserted-by":"crossref","DOI":"10.3390\/cancers12061507","article-title":"Small non-coding RNA profiling in plasma extracellular vesicles of bladder cancer patients by next-generation sequencing: expression levels of miR-126-3p and piR-5936 increase with higher histologic grades","volume":"12","author":"Sabo","year":"2020","journal-title":"Cancers"},{"key":"10.1016\/j.ejca.2026.116987_bib25","doi-asserted-by":"crossref","first-page":"8075","DOI":"10.1007\/s13277-015-4698-y","article-title":"Circulating miR-205: a promising biomarker for the detection and prognosis evaluation of bladder cancer","volume":"37","author":"Fang","year":"2016","journal-title":"Tumour Biol"},{"key":"10.1016\/j.ejca.2026.116987_bib26","article-title":"Serum miR-210 contributes to tumor detection, stage prediction and dynamic surveillance in patients with bladder cancer","volume":"10","author":"Yang","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.ejca.2026.116987_bib27","doi-asserted-by":"crossref","first-page":"7420","DOI":"10.7150\/thno.77761","article-title":"Identification of a miRNA-based non-invasive predictive biomarker of response to target therapy in BRAF-mutant melanoma","volume":"12","author":"Ruggiero","year":"2022","journal-title":"Theranostics"},{"key":"10.1016\/j.ejca.2026.116987_bib28","doi-asserted-by":"crossref","first-page":"3201","DOI":"10.7150\/ijbs.96831","article-title":"Hypoxic tumor-derived exosomal miR-4488 induces macrophage M2 polarization to promote liver metastasis of pancreatic neuroendocrine neoplasm through RTN3\/FABP5 mediated fatty acid oxidation","volume":"20","author":"Lu","year":"2024","journal-title":"Int J Biol Sci"},{"key":"10.1016\/j.ejca.2026.116987_bib29","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.radonc.2020.06.022","article-title":"Methylation-associated silencing of miR-193b improves the radiotherapy sensitivity of esophageal cancer cells by targeting cyclin D1 in areas with zinc deficiency","volume":"150","author":"Jin","year":"2020","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ejca.2026.116987_bib30","doi-asserted-by":"crossref","first-page":"181","DOI":"10.3892\/ol.2024.14314","article-title":"Liquid biopsy utilizing miRNA in patients with advanced breast cancer treated with cyclin\u2011dependent kinase 4\/6 inhibitors","volume":"27","author":"Kubeczko","year":"2024","journal-title":"Oncol Lett"},{"key":"10.1016\/j.ejca.2026.116987_bib31","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1038\/s41420-025-02348-5","article-title":"Comparative microRNA signatures based on liquid biopsy to identify lymph node metastasis in T1 colorectal cancer patients undergoing upfront surgery or endoscopic resection","volume":"11","author":"Okamoto","year":"2025","journal-title":"Cell Death Discov"},{"key":"10.1016\/j.ejca.2026.116987_bib32","article-title":"Circulating miR-92b and miR-375 for monitoring the chemoresistance and prognosis of small cell lung cancer","volume":"10","author":"Li","year":"2020","journal-title":"Sci Rep"},{"key":"10.1016\/j.ejca.2026.116987_bib33","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1530\/ERC-17-0389","article-title":"Circulating miR-375 as a novel prognostic marker for metastatic medullary thyroid cancer patients","volume":"25","author":"Romeo","year":"2018","journal-title":"Endocr Relat Cancer"},{"key":"10.1016\/j.ejca.2026.116987_bib34","doi-asserted-by":"crossref","first-page":"5873","DOI":"10.1158\/1078-0432.CCR-18-1184","article-title":"Circulating cell-free miR-375 as surrogate marker of tumor burden in merkel cell carcinoma","volume":"24","author":"Fan","year":"2018","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.ejca.2026.116987_bib35","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1016\/j.tranon.2019.04.014","article-title":"Circulating exosomal miR-141-3p and miR-375 in metastatic progression of rectal cancer","volume":"12","author":"Meltzer","year":"2019","journal-title":"Transl Oncol"},{"key":"10.1016\/j.ejca.2026.116987_bib36","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1186\/s12885-021-08729-0","article-title":"Circulating MiR-1290 as a potential diagnostic and disease monitoring biomarker of human gastrointestinal tumors","volume":"21","author":"Xu","year":"2021","journal-title":"BMC Cancer"},{"key":"10.1016\/j.ejca.2026.116987_bib37","doi-asserted-by":"crossref","first-page":"1879","DOI":"10.1093\/annonc\/mdw279","article-title":"Circulating microRNA-1290 as a novel diagnostic and prognostic biomarker in human colorectal cancer","volume":"27","author":"Imaoka","year":"2016","journal-title":"Ann Oncol"},{"key":"10.1016\/j.ejca.2026.116987_bib38","article-title":"Tumour-initiating cell-specific miR-1246 and miR-1290 expression converge to promote non-small cell lung cancer progression","volume":"7","author":"Zhang","year":"2016","journal-title":"Nat Commun"},{"key":"10.1016\/j.ejca.2026.116987_bib39","doi-asserted-by":"crossref","first-page":"1764","DOI":"10.1007\/s12094-022-02831-w","article-title":"miR-1290 modulates the radioresistance of triple-negative breast cancer by targeting NLRP3-mediated pyroptosis","volume":"24","author":"Li","year":"2022","journal-title":"Clin Transl Oncol"},{"key":"10.1016\/j.ejca.2026.116987_bib40","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2022.215726","article-title":"Breast cancer extracellular vesicles-derived miR-1290 activates astrocytes in the brain metastatic microenvironment via the FOXA2-->CNTF axis to promote progression of brain metastases","volume":"540","author":"Sirkisoon","year":"2022","journal-title":"Cancer Lett"},{"key":"10.1016\/j.ejca.2026.116987_bib41","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.eururo.2014.07.035","article-title":"Exosomal miR-1290 and miR-375 as prognostic markers in castration-resistant prostate cancer","volume":"67","author":"Huang","year":"2015","journal-title":"Eur Urol"},{"key":"10.1016\/j.ejca.2026.116987_bib42","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1002\/pros.23452","article-title":"Circulating microRNAs and treatment response in the phase II SWOG S0925 study for patients with new metastatic hormone-sensitive prostate cancer","volume":"78","author":"Cheng","year":"2018","journal-title":"Prostate"},{"key":"10.1016\/j.ejca.2026.116987_bib43","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1093\/clinchem\/hvaa095","article-title":"Prognostic value of novel liquid biomarkers in patients with metastatic castration-resistant prostate cancer treated with enzalutamide: a prospective observational study","volume":"66","author":"Benoist","year":"2020","journal-title":"Clin Chem"},{"key":"10.1016\/j.ejca.2026.116987_bib44","doi-asserted-by":"crossref","DOI":"10.1016\/j.gene.2024.149186","article-title":"Comparative analysis of extracellular vesicles miRNAs (EV-miRNAs) and cell-free microRNAs (cf-miRNAs) reveals that EV-miRNAs are more promising as diagnostic and prognostic biomarkers for prostate cancer","volume":"939","author":"Nobrega","year":"2025","journal-title":"Gene"}],"container-title":["European Journal of Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0959804926007689?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0959804926007689?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T16:09:16Z","timestamp":1789056556000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0959804926007689"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":44,"alternative-id":["S0959804926007689"],"URL":"https:\/\/doi.org\/10.1016\/j.ejca.2026.116987","relation":{},"ISSN":["0959-8049"],"issn-type":[{"value":"0959-8049","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Liquid biopsy miRNA risk score in bladder cancer: Translational insights from patient-derived xenografts to prognostic stratification","name":"articletitle","label":"Article Title"},{"value":"European Journal of Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejca.2026.116987","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"116987"}}